Pancreatic acinar cell carcinoma with extension into the main pancreatic duct: a case report

被引:6
|
作者
Kayahara, Masato [1 ]
Onishi, Ichiro [1 ]
Makita, Naoki [1 ]
Kano, Shunsuke [1 ]
Munemoto, Masayoshi [1 ]
Yagi, Yasumichi [1 ]
Minami, Makiko [2 ]
Orita, Noriaki [3 ]
Komura, Takuya [3 ]
Kurose, Nozomu [4 ]
机构
[1] NHO Kanazawa Med Ctr, Dept Surg, 1-1 Shimoishibiki Cho, Kanazawa, Ishikawa 9208650, Japan
[2] NHO Kanazawa Med Ctr, Dept Radiol, 1-1 Shimoishibiki Cho, Kanazawa, Ishikawa 9208650, Japan
[3] NHO Kanazawa Med Ctr, Dept Gastroenterol, 1-1 Shimoishibiki Cho, Kanazawa, Ishikawa 9208650, Japan
[4] NHO Kanazawa Med Ctr, Dept Pathol, 1-1 Shimoishibiki Cho, Kanazawa, Ishikawa 9208650, Japan
关键词
Pancreatic acinar cell carcinoma; Main pancreatic duct extension; EUS-FNA;
D O I
10.1186/s40792-021-01172-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundPancreatic acinar cell carcinoma (PACC) is a rare exocrine malignant tumor. Its widespread intraductal extension into the main pancreatic duct (MPD) is also rare.Case presentationWe report the case of a 71-year-old man with PACC with MPD extension. The patient was assessed with laboratory and radiographic investigations that facilitated a preoperative diagnosis. Endoscopic ultrasonography (EUS) and dynamic thin-slice multi-detector row computed tomography (MDCT) were useful for determining the resection line of the pancreas. EUS-guided fine needle aspiration (EUS-FNA) was also helpful in determining the tumor biology and treatment strategy. Distal pancreatectomy was performed. The MPD was occupied by the tumor 35 mm downstream and 5 mm upstream. Histopathologically, the pancreatic tail tumor extended continuously into the MPD. The tumor was solid with cells showing eosinophilic and granular cytoplasm, indicating the diagnosis of PACC. This is an interesting case of PACC with intraductal extension into the MPD. We discuss the possible mechanisms of tumor extension in this rare case together with a review of the literature.ConclusionsWe describe a rare pancreatic acinar cell carcinoma that could be adequately treated using preoperative precise imaging and histopathological evaluations. When an intraductal tumor extension in the MPD is encountered, the diagnosis of a rare pancreatic tumor should be considered, as in our case.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Acinar cell carcinoma of the pancreas presenting as diffuse pancreatic enlargement Two case reports and literature review
    Luo, Yaping
    Hu, Guilan
    Ma, Yanru
    Guo, Ning
    Li, Fang
    MEDICINE, 2017, 96 (38)
  • [22] Successful curative treatment for a ruptured pancreatic acinar cell carcinoma by radical resection following modified FOLFIRINOX: a case report and literature review
    Yamane, Kei
    Tsukano, Kosuke
    Umino, Yosuke
    Nagami, Tadashi
    Tarumoto, Koji
    Hattori, Kuniaki
    Maemoto, Ryo
    Iwasaki, Junji
    Kanazawa, Akiyoshi
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2024, 13 (03) : 281 - 288
  • [23] Rare ROS1-CENPW gene in pancreatic acinar cell carcinoma and the effect of crizotinib plus AG chemotherapy: A case report
    Wang, Tao
    Shen, Yi-Yu
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (24) : 5823 - 5829
  • [24] Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma
    Huang, Xing
    Li, Mao
    Zhang, Ling
    Xiong, Junjie
    Lu, Huimin
    Tian, Bole
    SURGICAL ONCOLOGY-OXFORD, 2021, 37
  • [25] Successful conversion surgery after FOLFIRINOX therapy in a patient with advanced pancreatic acinar cell carcinoma with a solitary peritoneal dissemination: A case report
    Uemura, Sunao
    Maeda, Hiromichi
    Tanioka, Nobuhisa
    Yamaguchi, Sachi
    Munekage, Masaya
    Kitagawa, Hiroyuki
    Namikawa, Tsutomu
    Yamamoto, Shota
    Kohsaki, Takuhiro
    Iguchi, Mitsuko
    Uchida, Kazushige
    Hanazaki, Kazuhiro
    CANCER REPORTS, 2022, 5 (09)
  • [26] Pathological complete response with FOLFIRINOX therapy for recurrence of pancreatic acinar cell carcinoma
    Teramatsu, Katsuhito
    Fujimori, Nao
    Murakami, Masatoshi
    Yasumori, Sho
    Matsumoto, Kazuhide
    Nakata, Kohei
    Nakamura, Masafumi
    Koga, Yutaka
    Oda, Yoshinao
    Ogawa, Yoshihiro
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2024, 17 (04) : 776 - 781
  • [27] The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review
    Matsubayashi, Hiroyuki
    Todaka, Akiko
    Tsushima, Takahiro
    Kiyozumi, Yoshimi
    Harada, Rina
    Ishihara, Eiko
    Higashigawa, Satomi
    Ohike, Nobuyuki
    Sakamoto, Hiroki
    Sato, Junya
    Ishiwatari, Hirotoshi
    Sugiura, Teichi
    Uesaka, Katsuhiko
    FAMILIAL CANCER, 2024, 23 (03) : 393 - 398
  • [28] Pancreatic acinar cell carcinoma with bilateral ovarian metastases, panniculitis and polyarthritis treated with FOLFIRINOX chemotherapy regimen. A case report and review of the literature
    Callata-Carhuapoma, Hector R.
    Pato Cour, Esperanza
    Garcia-Paredes, Beatriz
    Mendez Fernandez, Ramiro
    Mendoza Fernandez, Maria Luisa
    Manzano Fernandez, Aranzazu
    Aguado De La Rosa, Carlos
    Sotelo Lezama, Miguel J.
    Cabezas-Camarero, Santiago
    Sastre Varela, Javier
    PANCREATOLOGY, 2015, 15 (04) : 440 - 444
  • [29] Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of Literature
    Xu, Jian-Ying
    Guan, Wen-Long
    Lu, Shi-Xun
    Wei, Xiao-Li
    Shi, Wen-Jie
    Ren, Chao
    Li, Yu-Hong
    Li, Sheng-Ping
    Qiu, Miao-Zhen
    Wang, Feng-Hua
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2022, 16
  • [30] EXPRESSION OF CLAUDIN-5 IN CANINE PANCREATIC ACINAR CELL CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY
    Jakab, Csaba
    Rusvai, Miklos
    Galfi, Peter
    Halasz, Judit
    Kulka, Janina
    ACTA VETERINARIA HUNGARICA, 2011, 59 (01) : 87 - 98